Skip to content

The Effect of Postoperative Incentive Spirometry on Pulmonary Function and Pulmonary Complications in Bariatric Surgery

The Effect of Postoperative Incentive Spirometry on Pulmonary Function and Pulmonary Complications in Bariatric Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02431455
Enrollment
224
Registered
2015-05-01
Start date
2015-06-30
Completion date
2016-05-31
Last updated
2016-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Morbid, Complications of Bariatric Procedures, Pulmonary Atelectasis, Pneumonia

Keywords

Bariatric Surgery, obesity, morbid, incentive spirometry

Brief summary

This study evaluates the omission of incentive spirometry use following bariatric surgery. Half of participants will receive an incentive spirometer while the other half will not. Oxygen saturation and pulmonary complications after surgery will be measured to examine the effectiveness of incentive spirometry.

Detailed description

Incentive spirometry is speculated to improve pulmonary function in the postoperative period, though data to support this is lacking. Patients undergoing bariatric surgery are at increased risk for pulmonary compromise as they are obese and undergoing foregut surgery. This study aims to examine the effect of incentive spirometry after bariatric surgery by performing a prospective randomized trial. Subjects will be randomized to either receive an incentive spirometer or not. The primary outcome measure of oxygen saturation off of supplemental oxygen will be taken preoperatively and at 6,12, and 24 hours postoperatively. Secondary outcome measures include rate of pulmonary complications, and time to wean off of supplemental oxygen.

Interventions

Incentive spirometer is provided to the patient, this is the current standard of care, and is the control arm.

DEVICENo incentive spirometer

No incentive spirometer is provided to the patient, this is the study arm.

Sponsors

Lahey Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients medically cleared to undergo bariatric surgery per the usual screening process

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Hypoxia 6 Hours Postoperative6 hours postoperativeNumber of subjects with pulse oximetry reading of \< 92% with subject off of supplemental oxygen for 5 minutes with head of bed at 30°, 6 hours postoperative.
Hypoxia 12 Hours Postoperative12 hours postoperativeNumber of subjects with pulse oximetry reading of \< 92% with subject off of supplemental oxygen for 5 minutes with head of bed at 30°, 12 hours postoperative.
Hypoxia 24 Hours Postoperative24 hours postoperativeNumber of subjects with pulse oximetry reading of \< 92% with subject off of supplemental oxygen for 5 minutes with head of bed at 30°, 24 hours postoperative.

Secondary

MeasureTime frameDescription
Postoperative Respiratory Complicationentire inpatient say, usually 1 to 7 daysatelectasis found on chest imaging, pneumonia, or re intubation

Countries

United States

Participant flow

Participants by arm

ArmCount
Incentive Spirometry
Incentive spirometry 10 times per hour while awake Incentive spirometer: Incentive spirometer is provided to the patient, this is the current standard of care, and is the control arm.
112
No Incentive Spirometry
No incentive spirometer provided No incentive spirometer: No incentive spirometer is provided to the patient, this is the study arm.
112
Total224

Baseline characteristics

CharacteristicIncentive SpirometryNo Incentive SpirometryTotal
Age, Continuous45.2 years
STANDARD_DEVIATION 12.4
45.9 years
STANDARD_DEVIATION 11.1
45.6 years
STANDARD_DEVIATION 11.7
Sex: Female, Male
Female
88 Participants86 Participants174 Participants
Sex: Female, Male
Male
24 Participants26 Participants50 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1120 / 112
serious
Total, serious adverse events
0 / 1120 / 112

Outcome results

Primary

Hypoxia 12 Hours Postoperative

Number of subjects with pulse oximetry reading of \< 92% with subject off of supplemental oxygen for 5 minutes with head of bed at 30°, 12 hours postoperative.

Time frame: 12 hours postoperative

ArmMeasureValue (NUMBER)
Incentive SpirometryHypoxia 12 Hours Postoperative6 participants
No Incentive SpirometryHypoxia 12 Hours Postoperative9 participants
Primary

Hypoxia 24 Hours Postoperative

Number of subjects with pulse oximetry reading of \< 92% with subject off of supplemental oxygen for 5 minutes with head of bed at 30°, 24 hours postoperative.

Time frame: 24 hours postoperative

ArmMeasureValue (NUMBER)
Incentive SpirometryHypoxia 24 Hours Postoperative4 participants
No Incentive SpirometryHypoxia 24 Hours Postoperative5 participants
Primary

Hypoxia 6 Hours Postoperative

Number of subjects with pulse oximetry reading of \< 92% with subject off of supplemental oxygen for 5 minutes with head of bed at 30°, 6 hours postoperative.

Time frame: 6 hours postoperative

ArmMeasureValue (NUMBER)
Incentive SpirometryHypoxia 6 Hours Postoperative13 participants
No Incentive SpirometryHypoxia 6 Hours Postoperative11 participants
Secondary

Postoperative Respiratory Complication

atelectasis found on chest imaging, pneumonia, or re intubation

Time frame: entire inpatient say, usually 1 to 7 days

ArmMeasureValue (NUMBER)
Incentive SpirometryPostoperative Respiratory Complication8 participants
No Incentive SpirometryPostoperative Respiratory Complication4 participants

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026